Inhibition of p38α MAPK increases short-term astrocyte reactivity: the exploratory VIP trial in early Alzheimer’s disease
Dominique Gouilly, Adriana DaCosta, Agathe Vrillon, Aurélie Pistono et autres
1 citationJournal of Neuroinflammation
Marie Goubeaud
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
23Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsS100 Proteins and AnnexinsDementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications
Publications récentes
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials
Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese et autres
0 citationsnpj Parkinson s Disease
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab
Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar et autres
14 citationsnpj Digital Medicine
Translocator Protein (Tspo) Genotype Does Not Change Cerebrospinal Fluid Levels of Neuro-Inflammation, Axonal and Synaptic Damage Markers in Early Alzheimer's Disease
Dominique Gouilly, Agathe Vrillon, E Bertrand, Marie Goubeaud et autres
0 citationsSSRN Electronic Journal
Translocator protein (TSPO) genotype does not change cerebrospinal fluid levels of glial activation, axonal and synaptic damage markers in early Alzheimer’s disease
Dominique Gouilly, Agathe Vrillon, E Bertrand, Marie Goubeaud et autres
1 citationNeuroImage Clinical
Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
Dominique Gouilly, Anne‐Sophie Salabert, E Bertrand, Marie Goubeaud et autres
7 citationsFrontiers in Neurology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.